INTRODUCTION
Biomarkers are measures of biological parameters of disease that also can predict which new molecular entities will be effective and safe in treating patients (1) . We have focused our biomarker discovery efforts on the analysis of mouse models (2) in order to avoid the interindividual differences of human specimens that often result in a low biomarker signal to background noise ratio.
The manifestation of anxiety in a number of psychiatric disorders such as generalized anxiety disorder, depression, panic attacks, phobias, obsessive-compulsive disorders and posttraumatic stress disorder (3) highlights the importance of gaining a better understanding of associated reliable biomarkers in proper animal models. An animal model to study behavioral, neuroendocrine and genetic concomitants of trait anxiety including psychopathology should represent a good approximation to score symptoms of anxiety disorders and possibly comorbid depression (4, 5, 6) . In order to avoid inter-strain comparisons, likely to reveal differences in more than just anxiety-related indices, we have been using intra-strain breeding approaches to focus on particular traits, including anxiety-related behavior (7), depressionlike behavior (8) , avoidance behavior or receptor functions likely to be associated with differences in anxiety (9, 10, 11, 12) . The technique of selective bidirectional breeding enhances the representation of genetic material associated with a particular trait shifting the animals' phenotype bidirectionally from the strain mean (13) .
Genetic approaches currently available in the mouse make this model organism particularly powerful for the functional analysis of candidate genes and in defining gene products underlying trait anxiety and possibly depression (14) . For this reason we have generated and validated hyper-anxious (HAB-M) and hypo-anxious (LAB-M) CD1 mouse lines as model of extremes in trait anxiety and have used comparative proteomics to identify anxiety-related protein markers (2) . One of the identified markers, glyoxalase-I, shows expression level differences between HAB-M and LAB-M animals and recently has attracted increasing attention for its role in psychopathogenic mechanisms (15) . The other protein that exhibits a qualitative difference of unknown nature between the two mouse strains is enolase phosphatase.
EXPERIMENTAL PROCEDURES
Mice. The animal studies were conducted in accordance with the "Guide for the Care and Use of Laboratory Animals of the Government of Bavaria". Mice were housed in groups of three to five in plastic cages (25 x 20 x 14 cm) with a 12-h light/dark schedule (lights on at 6 a.m.) at 23°C, 60% humidity with food and tap water available ad libitum. Experiments were carried out between 8 a.m. and 12 p.m. As previously described (2) we used over 250 animals from more than 25 litters of the outbred Swiss CD1 strain (Charles River, Sulzfeld, Germany) as a starting point for selective and bidirectional breeding for anxiety-related behavior on the EPM at the age of seven weeks. Males and females that spent either the least or most time on the open arms of the EPM were mated to establish the HAB-M and LAB-M mouse lines, respectively. The first generation (G1) was weaned and separated by sex at three weeks of age and tested on the EPM four weeks later. Again, extremes were mated and offspring was reared in the same manner for all following generations. Outbreeding across families but within closed lines was practiced in order to minimize random fixation of alleles other than those selected for, and also to maximize the number of genes influencing anxiety-related behavior within each line. After nine generations of outbreeding, an inbreeding protocol was started based on strict sib-mating. We generated 4-6 independent families within the HAB-M and LAB-M lines, respectively. In the experiments, animals from all inbred HAB-M and LAB-M families from seven generations (G12-G18) were included to avoid both fortuitous correlations and fluctuations across time due to genetic drift (8) .
CM-M offspring comprised reciprocal crosses between HAB-M and LAB-M mice. They were housed under the same conditions as HAB-M, LAB-M and "normal" CD1 (NAB-M) animals, the latter being selected as controls independent of their performance on the EPM. All behavioral tests were conducted during weeks 7 to 13. Mice were initially tested on the EPM and, at least two days later, in one or more additional tests. The minimum recovery time between the tests was one day. Gels were stained with colloidal Coomassie Blue and scanned. The scanned images were analyzed and compared to each other with the help of PDQUEST software (BioRad).
Spots were detected using the automated spot detection and matching function. After normalization according to total density spot intensities were quantitated and compared between the replicate groups (HAB, LAB, NAB). Group differences were evaluated statistically applying the student t-test with a significance level of 98 % and the criteria of a minimum of twofold difference (increase or decrease) in spot intensity. The automated analysis was completed by manual matching and quantitation of spots of interest.
Mass Spectrometry. Gel spots that represented differences in protein expression levels based on the results from the image analysis were subjected to an in-gel tryptic digest. For this purpose, 50 µl 20 mM ammonium bicarbonate/acetonitrile (1:1) was used for gel cleanup and drying. After the gel pieces were dry, 30 µl 20 mM ammonium bicarbonate containing 0.5 µg trypsin (Promega, Madison, WI) was added and incubated at 37°C overnight. Peptides were extracted twice with 25 µl 5% formic acid by incubation at 37°C for 30 min. The extracts were concentrated in a speedvac and re-dissolved in 12 µl 0.1% formic acid. For mass spectrometry analysis, the tryptic digests were injected onto a C18 cartridge using a FAMOS Autosampler (Dionex, Sunnyvale, CA). After washing the cartridge with 0.1% formic acid 
RESULTS
In our efforts to identify biomarkers for trait anxiety, a mouse model was established by using a bidirectional inbreeding protocol. Anxiety-like behavior on the elevated plus maze was the key selection criterion (Fig. 1A) . The increasing divergence between HAB-M and LAB-M animals is depicted in Both behavioral assays, the EPM and the forced swim test, showed a very consistent difference in the phenotype of the two mouse strains, which was a prerequisite for subsequent proteomic analyses.
For biomarker identification, protein extracts from individual brain areas from HAB-M and LAB-M mice were subjected to 2D-PAGE (Fig. 3) . The first dimension IEF was run with a pH gradient of 4-7 and the second dimension in a 12% SDS gel. After staining the gels with colloidal Coomassie Blue, the scanned images were compared by computer analysis. Each gel contained approximately 800 detectable protein spots. One of the protein spots differed significantly in its intensity between all the HAB-M and LAB-M animals in all three brain areas analyzed (hypothalamus, amygdala, motor cortex). In order to obtain a good estimate of the relative expression levels, we used Western blot analysis. Based on the signal intensity of the Glx1 protein band, the level of this protein's expression was approximately tenfold higher in LAB-M compared to HAB-M animals (Fig. 4A,B) . Another protein showed a different migration pattern in the gels indicating a qualitative variance that is either due to an altered post-translational modification or an allelic difference. In HAB-M animal tissue extracts, the EP protein exhibits a slower mobility in the second dimension than for LAB-M and NAB-M Since 2D-PAGE is a rather laborious method for studying protein expression in tissues, we next wished to set up a high throughput method for the quantitative analysis of Glx1 and EP.
Since Glx1 is expressed ubiquitously in many cells and tissues (17), we were able to use red blood cells as a source from now on. The protein sequence of Glx1 is highly conserved among higher vertebrates, which allowed us to use a polyclonal antiserum that was generated against human Glx1 for the detection of the mouse enzyme by Western blot analysis (Fig.   4A ). In the case of EP we obtained an antibody from a commercial source. Since EP is not expressed in red blood cells, we used HAB-M and LAB-M mouse brain tissue to validate the expression difference that we had observed in 2D-PAGE (Fig. 4C ).
In the case of Glx1 the Western blot enabled us to screen a great number of mouse red blood cell specimens. To extend our studies, we now also included samples from "normal" NAB-M and cross-mated CM-M controls, which displayed intermediate scores in the EPM test (Fig.   4A ). Independent of their gender, both groups, NAB-M and CM-M animals, also showed intermediate levels of Glx1 expression as compared to LAB-M and HAB-M mice, the former again expressing significantly more Glx1 thus confirming the brain tissue data (Fig. 4A,B) .
Enolase phosphatase Western blot analysis of HAB-M and LAB-M mouse brain tissue revealed a complex expression pattern when 2D-PAGE was used for protein separation (Fig.   4C ). Despite its complexity an additional spot that migrates slower in the second dimension SDS gel was detected in HAB-M brain tissue extracts and was absent in LAB-M extracts.
This isoform pattern is in agreement with the one observed in the original 2D-PAGE analysis of brain tissue from the two mouse strains (Fig. 3) . The nature of the different isoform in HAB-M animals is currently under investigation.
In an extension of our studies we have begun to screen human specimens with the long-term goal to correlate the expression of biomarkers that were identified in mouse models with disease phenotypes in humans. Working to our advantage both, Glx1and EP, are expressed in blood cells which are isolated on a routine basis in clinical laboratories. Whereas Glx1 is found in red blood cells, EP expression can be analyzed in white blood cells as a source.
Preliminary screens with a limited number of patient specimens show that both proteins can be detected by Western blot analysis from these cells (Fig. 5 ). In the case of EP the two immunoreactive bands comigrate with the two spots that were originally detected during 2D-PAGE of the HAB-M and LAB-M amygdala extracts. Due to the small amount of patient blood specimens, we were unable to produce a Coomassie-stained 2D gel of the white blood cell extracts.
DISCUSSION
Selective and bidirectional breeding of CD1 mice for either high or low anxiety-related behavior resulted in two inbred lines that, independent of their gender, differ extremely in a variety of behavioral paradigms (2). The EPM, based on spontaneous, unconditioned behavior, was selected as an initial key evaluation tool. LAB-M mice were not only less anxious compared to HAB-M mice in the EPM test but also showed lower immobility scores in the forced swim test, indicative of a reduced depression-like behavior. Using 2D-PAGE of several brain tissue sections (hypothalamus, amygdala, cortex) and subsequently Western blot analysis, Glx1 and EP were identified as protein markers, which are consistently expressed at a different level or with an altered pattern, respectively. Other spot differences were not observed in a consistent manner. In our experience the method of 2D-PAGE followed by Coomassie Blue staining is only capable of detecting significant differences of abundant proteins. For a more sensitive analysis of the trait anxiety mouse model proteins, we are planning to use a stable isotope-based proteomics platform in the future. A major goal in the area of mental disorders is the identification of biomarkers that can categorize subsets of subjects in a more reliable and consistent manner. Our approach demonstrates that proteomic analyses are suited to identify protein markers that are differentially expressed in CD1 mice with different genetic predispositions to anxiety-related behavior. Glx1 represents an enzyme in the cytosolic fraction of cells and tissues of many organisms (17, 19) . Although its function is not entirely clear, it has been shown that the enzyme plays a major role in the detoxification of methylglyoxal, which represents a potent cytotoxic metabolite. Glx1 catalyzes the transformation of methylglyoxal and glutathione to S-lactoylglutathione, which is converted to D-lactic acid by glyoxalase-II (19) . Due to its ubiquitous expression, the methylglyoxal pathway is believed to be of fundamental importance for cellular metabolism. Glx1 was identified as the only up-regulated gene in mutant mice sharing common pathogenic mechanisms with Alzheimer patients (15) . A possible connection between Glx1 and depression has been found in a linkage study of families with depressive disease. Subgroups of families with unipolar affective disease showed evidence for a linkage or association with the Glx1 locus (20) . In a recent study using different inbred strains of mice Hovatta et al. found that Glx1 and glutathione reductase 1 play a causal role in anxiety (21) . It remains to be seen if Glx1 represents a risk marker or a risk factor for the anxiety-related phenotype in mice (22) . Very little has been reported on the function of the other marker protein that was identified in our analysis. As its name indicates, EP is an enzyme that has both, enolase and phosphatase activities, and is involved in metabolic pathways of energy production and conversion (23) .
No association with any disease has been reported to this date. The nature of the different isoforms that were found in HAB-M and LAB-M mice is currently under investigation.
The expression of both marker proteins, Glx1 and EP, can be assessed in human specimens by isolating red and white blood cells, respectively. Future studies with a great number of case and control specimens will tell if the two proteins can be used in the diagnosis of anxiety disorders in patients. 
